No Impact of HIV-1 Protease Minority Resistant Variants on the Virological Response to a First-Line PI-based Regimen Containing Darunavir or Atazanavir - Sorbonne Université
Journal Articles Journal of Antimicrobial Chemotherapy Year : 2018

No Impact of HIV-1 Protease Minority Resistant Variants on the Virological Response to a First-Line PI-based Regimen Containing Darunavir or Atazanavir

Dates and versions

hal-03793517 , version 1 (01-10-2022)

Identifiers

Cite

Marine Perrier, Benoit Visseaux, Roland Landman, Véronique Joly, Eve Todesco, et al.. No Impact of HIV-1 Protease Minority Resistant Variants on the Virological Response to a First-Line PI-based Regimen Containing Darunavir or Atazanavir. Journal of Antimicrobial Chemotherapy, 2018, 73 (1), pp.173--176. ⟨10.1093/jac/dkx366⟩. ⟨hal-03793517⟩
21 View
0 Download

Altmetric

Share

More